Post-Vaccination Care and Monitoring
Adverse Event Timeline
- The Centers for Disease Control and Prevention recommends monitoring for fever and rash, which typically appear 7-10 days post-vaccination in approximately 5% of recipients 2, 3
- The Centers for Disease Control and Prevention notes that febrile seizures occur within the first 5-14 days, with a risk of approximately 1 per 3,000 doses 2, 4
- Joint symptoms, primarily in postpubertal females, begin 1-3 weeks after vaccination and persist for 1 day to 3 weeks 4, 5
- Thrombocytopenia typically manifests within approximately 6 weeks post-vaccination 6
- Encephalopathy is extremely rare, with an onset approximately 10 days after vaccination, occurring in approximately 1 per 2 million doses 2
Immunity and Follow-Up
- The Centers for Disease Control and Prevention states that vaccine-induced immunity is established within 1-2 weeks of vaccination 6
- No delayed adverse events occurring beyond the initial weeks post-vaccination have been documented in the medical literature 2, 4
Special Considerations
- The Centers for Disease Control and Prevention recommends that women of childbearing age who received MMR within the past year should have been counseled to avoid pregnancy for 3 months (or 28 days per most recent guidance) post-vaccination 7, 8
Serologic Testing
- The Centers for Disease Control and Prevention notes that routine serologic testing to confirm immunity is not recommended after standard MMR vaccination in immunocompetent individuals, but may be considered in specific circumstances, such as for healthcare workers in outbreak settings 7
- The Infectious Diseases Society of America recommends serologic testing for immunocompromised patients who received vaccination 9
- The Centers for Disease Control and Prevention suggests serologic testing for international adoptees with uncertain vaccination history 10